Home/Filings/4/0000899243-22-035755
4//SEC Filing

Weill David 4

Accession 0000899243-22-035755

CIK 0001756262other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 7:17 PM ET

Size

8.2 KB

Accession

0000899243-22-035755

Insider Transaction Report

Form 4
Period: 2022-11-10
Weill David
Director
Transactions
  • Sale

    Common Stock

    2022-11-10$56.00/sh21,645$1,212,12013,500 total
  • Exercise/Conversion

    Common Stock

    2022-11-10$16.00/sh+21,645$346,32035,145 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2022-11-1021,6450 total
    Exercise: $16.00Exp: 2029-05-01Common Stock (21,645 underlying)
Footnotes (1)
  • [F1]The option is fully vested.

Issuer

TransMedics Group, Inc.

CIK 0001756262

Entity typeother

Related Parties

1
  • filerCIK 0001774270

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 7:17 PM ET
Size
8.2 KB